SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2019-04-24 13:50
Tx date 2019-04-17 		$CMTA
Clementia Pharmaceuticals Inc. 		Heft, Robert
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
59 - Exercise for cash 		$-275,250
-11,010 vol
$25.00 each 		0
Filed 2019-04-24 13:48
Tx date 2019-04-17 		$CMTA
Clementia Pharmaceuticals Inc. 		Heft, Robert
4 - Director of Issuer
Direct Ownership
Options
59 - Exercise for cash
-102,683 vol 		0
Filed 2019-04-24 13:47
Tx date 2019-04-17 		$CMTA
Clementia Pharmaceuticals Inc. 		Heft, Robert
4 - Director of Issuer
Holder: Gren Trust (Control or Direction)
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition 		$-1,597,375
-63,895 vol
$25.00 each 		0
Filed 2019-04-22 11:11
Tx date 2019-04-17 		$CMTA
Clementia Pharmaceuticals Inc. 		Tomasello, Shawn Cline
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
59 - Exercise for cash 		$-239,775
-9,591 vol
$25.00 each 		0
Filed 2019-04-22 11:11
Tx date 2019-04-17 		$CMTA
Clementia Pharmaceuticals Inc. 		Tomasello, Shawn Cline
4 - Director of Issuer
Direct Ownership
Options
59 - Exercise for cash
-35,970 vol 		0
Filed 2019-04-22 11:06
Tx date 2019-04-17 		$CMTA
Clementia Pharmaceuticals Inc. 		Shih, Fei
5 - Senior Officer of Issuer
Direct Ownership
Options
59 - Exercise for cash
-84,950 vol 		0
Filed 2019-04-22 11:03
Tx date 2019-04-17 		$CMTA
Clementia Pharmaceuticals Inc. 		Roy Grogan, Donna
5 - Senior Officer of Issuer
Direct Ownership
Options
59 - Exercise for cash
-499,394 vol 		0
Filed 2019-04-22 11:02
Tx date 2019-04-17 		$CMTA
Clementia Pharmaceuticals Inc. 		Roy Grogan, Donna
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition 		$-1,746,650
-69,866 vol
$25.00 each 		0
Filed 2019-04-22 10:55
Tx date 2019-04-17 		$CMTA
Clementia Pharmaceuticals Inc. 		Packman, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
Options
59 - Exercise for cash
-353,379 vol 		0
Filed 2019-04-22 10:54
Tx date 2019-04-17 		$CMTA
Clementia Pharmaceuticals Inc. 		Packman, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition 		$-2,617,125
-104,685 vol
$25.00 each 		0
Filed 2019-04-22 10:51
Tx date 2019-04-17 		$CMTA
Clementia Pharmaceuticals Inc. 		Nader, Francois
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
59 - Exercise for cash 		$-280,200
-11,208 vol
$25.00 each 		0
Filed 2019-04-22 10:50
Tx date 2019-04-17 		$CMTA
Clementia Pharmaceuticals Inc. 		Nader, Francois
4 - Director of Issuer
Direct Ownership
Options
59 - Exercise for cash
-102,683 vol 		0
Filed 2019-04-22 10:49
Tx date 2019-04-17 		$CMTA
Clementia Pharmaceuticals Inc. 		Nader, Francois
4 - Director of Issuer
Direct Ownership
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition 		$-2,583,225
-103,329 vol
$25.00 each 		0
Filed 2019-04-22 10:45
Tx date 2019-04-17 		$CMTA
Clementia Pharmaceuticals Inc. 		Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
59 - Exercise for cash 		$-298,375
-11,935 vol
$25.00 each 		0
Filed 2019-04-22 10:44
Tx date 2019-04-17 		$CMTA
Clementia Pharmaceuticals Inc. 		Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
Options
59 - Exercise for cash
-142,681 vol 		0
Filed 2019-04-22 10:43
Tx date 2019-04-17 		$CMTA
Clementia Pharmaceuticals Inc. 		Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition 		$-1,468,775
-58,751 vol
$25.00 each 		0
Filed 2019-04-22 10:40
Tx date 2019-04-17 		$CMTA
Clementia Pharmaceuticals Inc. 		Legault, Pierre
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
59 - Exercise for cash 		$-280,800
-11,232 vol
$25.00 each 		0
Filed 2019-04-22 10:39
Tx date 2019-04-17 		$CMTA
Clementia Pharmaceuticals Inc. 		Legault, Pierre
4 - Director of Issuer
Direct Ownership
Options
59 - Exercise for cash
-35,970 vol 		0
Filed 2019-04-22 10:35
Tx date 2019-04-17 		$CMTA
Clementia Pharmaceuticals Inc. 		Walewicz, Joseph Andrew
5 - Senior Officer of Issuer
Direct Ownership
Options
59 - Exercise for cash
-191,720 vol 		0
Filed 2019-04-22 10:29
Tx date 2019-04-17 		$CMTA
Clementia Pharmaceuticals Inc. 		Grinstead, Eric
5 - Senior Officer of Issuer
Direct Ownership
Options
59 - Exercise for cash
-434,760 vol 		0
Filed 2019-04-22 10:19
Tx date 2019-04-17 		$CMTA
Clementia Pharmaceuticals Inc. 		Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
Options
59 - Exercise for cash
-389,100 vol 		0
Filed 2019-04-22 10:15
Tx date 2019-04-17 		$CMTA
Clementia Pharmaceuticals Inc. 		Desjardins, Clarissa
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
59 - Exercise for cash
-1,657,757 vol 		0
Filed 2019-04-22 10:14
Tx date 2019-04-17 		$CMTA
Clementia Pharmaceuticals Inc. 		Desjardins, Clarissa
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 3669661 Canada Inc. (Indirect Ownership)
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition 		$-20,351,350
-814,054 vol
$25.00 each 		0
Filed 2019-04-22 10:06
Tx date 2019-04-17 		$CMTA
Clementia Pharmaceuticals Inc. 		Bonita, David P.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
59 - Exercise for cash 		$-145,425
-5,817 vol
$25.00 each 		0
Filed 2019-04-22 10:06
Tx date 2019-04-17 		$CMTA
Clementia Pharmaceuticals Inc. 		Bonita, David P.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
59 - Exercise for cash
-47,960 vol 		0
Filed 2019-04-10 12:20
Tx date 2019-04-09 		$CMTA
Clementia Pharmaceuticals Inc. 		Desjardins, Clarissa
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 3669661 Canada Inc. (Indirect Ownership)
Common Shares
90 - Change in the nature of ownership
+814,054 vol 		814,054
Filed 2019-04-10 12:20
Tx date 2017-08-14 		$CMTA
Clementia Pharmaceuticals Inc. 		Desjardins, Clarissa
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 3669661 Canada Inc. (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-04-10 12:19
Tx date 2019-04-09 		$CMTA
Clementia Pharmaceuticals Inc. 		Desjardins, Clarissa
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
90 - Change in the nature of ownership
-814,054 vol 		0
Filed 2019-03-01
Tx date 2019-02-24 		$CMTA
Clementia Pharmaceuticals Inc. 		Tomasello, Shawn Cline
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
56 - Grant of rights
+7,845 vol 		9,591
Filed 2019-03-01
Tx date 2019-02-24 		$CMTA
Clementia Pharmaceuticals Inc. 		Legault, Pierre
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
56 - Grant of rights
+7,845 vol 		11,232
Filed 2019-03-01
Tx date 2019-02-24 		$CMTA
Clementia Pharmaceuticals Inc. 		Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
56 - Grant of rights
+7,845 vol 		11,935
Filed 2019-03-01
Tx date 2019-02-24 		$CMTA
Clementia Pharmaceuticals Inc. 		Nader, Francois
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
56 - Grant of rights
+7,845 vol 		11,208
Filed 2019-03-01
Tx date 2019-02-24 		$CMTA
Clementia Pharmaceuticals Inc. 		Heft, Robert
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
56 - Grant of rights
+7,845 vol 		11,010
Filed 2019-02-21
Tx date 2019-02-18 		$CMTA
Clementia Pharmaceuticals Inc. 		Packman, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+104,500 vol 		353,379
Filed 2019-02-21
Tx date 2019-02-18 		$CMTA
Clementia Pharmaceuticals Inc. 		Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+164,100 vol 		389,100
Filed 2019-02-21
Tx date 2019-02-18 		$CMTA
Clementia Pharmaceuticals Inc. 		Desjardins, Clarissa
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+463,300 vol 		1,657,757
Filed 2019-02-21
Tx date 2019-02-18 		$CMTA
Clementia Pharmaceuticals Inc. 		Roy Grogan, Donna
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+104,500 vol 		499,394
Filed 2019-02-21
Tx date 2019-02-18 		$CMTA
Clementia Pharmaceuticals Inc. 		Walewicz, Joseph Andrew
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+27,800 vol 		191,720
Filed 2019-02-18
Tx date 2019-02-15 		$CMTA
Clementia Pharmaceuticals Inc. 		BDC
3 - 10% Security Holder of Issuer
Holder: BDC Capital Inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-1,652,287.2144
-113,072 vol
$14.61 each 		5,338,069
Filed 2019-02-14
Tx date 2019-02-14 		$CMTA
Clementia Pharmaceuticals Inc. 		BDC
3 - 10% Security Holder of Issuer
Holder: BDC Capital Inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-121,088.048
-8,560 vol
$14.15 each 		5,451,141
Filed 2019-02-13
Tx date 2019-02-13 		$CMTA
Clementia Pharmaceuticals Inc. 		BDC
3 - 10% Security Holder of Issuer
Holder: BDC Capital Inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-100,714.796
-7,105 vol
$14.18 each 		5,459,701
Filed 2019-02-12
Tx date 2019-02-12 		$CMTA
Clementia Pharmaceuticals Inc. 		BDC
3 - 10% Security Holder of Issuer
Holder: BDC Capital Inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-285,925.0625
-20,405 vol
$14.01 each 		5,466,806
Filed 2019-02-11
Tx date 2019-02-11 		$CMTA
Clementia Pharmaceuticals Inc. 		BDC
3 - 10% Security Holder of Issuer
Holder: BDC Capital Inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-82,736.88
-5,900 vol
$14.02 each 		5,487,211
Filed 2019-02-06
Tx date 2019-02-05 		$CMTA
Clementia Pharmaceuticals Inc. 		BDC
3 - 10% Security Holder of Issuer
Holder: BDC Capital Inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-8,422.98
-600 vol
$14.04 each 		5,493,111
Filed 2019-02-04
Tx date 2019-02-04 		$CMTA
Clementia Pharmaceuticals Inc. 		BDC
3 - 10% Security Holder of Issuer
Holder: BDC Capital Inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-35,587
-2,500 vol
$14.23 each 		5,493,711
Filed 2019-01-18
Tx date 2019-01-18 		$CMTA
Clementia Pharmaceuticals Inc. 		BDC
3 - 10% Security Holder of Issuer
Holder: BDC Capital Inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-1,427
-100 vol
$14.27 each 		5,496,211
Filed 2019-01-16
Tx date 2019-01-16 		$CMTA
Clementia Pharmaceuticals Inc. 		BDC
3 - 10% Security Holder of Issuer
Holder: BDC Capital Inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-2,800
-200 vol
$14.00 each 		5,496,311
Filed 2019-01-15
Tx date 2019-01-14 		$CMTA
Clementia Pharmaceuticals Inc. 		BDC
3 - 10% Security Holder of Issuer
Holder: BDC Capital Inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-9,846.97
-700 vol
$14.07 each 		5,496,511
Filed 2019-01-14
Tx date 2019-01-11 		$CMTA
Clementia Pharmaceuticals Inc. 		BDC
3 - 10% Security Holder of Issuer
Holder: BDC Capital Inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-5,582.6496
-396 vol
$14.10 each 		5,497,211
Filed 2019-01-04
Tx date 2018-12-31 		$CMTA
Clementia Pharmaceuticals Inc. 		Heft, Robert
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
56 - Grant of rights
+850 vol 		3,165
Filed 2019-01-04
Tx date 2018-12-31 		$CMTA
Clementia Pharmaceuticals Inc. 		Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
56 - Grant of rights
+1,062 vol 		4,090
Filed 2019-01-04
Tx date 2018-12-31 		$CMTA
Clementia Pharmaceuticals Inc. 		Legault, Pierre
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
56 - Grant of rights
+1,142 vol 		3,387
Filed 2019-01-04
Tx date 2018-12-31 		$CMTA
Clementia Pharmaceuticals Inc. 		Bonita, David P.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
56 - Grant of rights
+1,514 vol 		5,817
Filed 2019-01-04
Tx date 2018-12-31 		$CMTA
Clementia Pharmaceuticals Inc. 		Tomasello, Shawn Cline
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
56 - Grant of rights
+850 vol 		1,746
Filed 2019-01-04
Tx date 2018-12-31 		$CMTA
Clementia Pharmaceuticals Inc. 		Nader, Francois
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
56 - Grant of rights
+903 vol 		3,363
Filed 2018-11-29
Tx date 2018-11-06 		$CMTA
Clementia Pharmaceuticals Inc. 		Legault, Pierre
4 - Director of Issuer
Direct Ownership
Options
56 - Grant of rights
+11,990 vol
Filed 2018-11-29
Tx date 2018-11-06 		$CMTA
Clementia Pharmaceuticals Inc. 		Bonita, David P.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+11,990 vol 		47,960
Filed 2018-11-29
Tx date 2018-11-06 		$CMTA
Clementia Pharmaceuticals Inc. 		Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+11,990 vol 		142,681
Filed 2018-11-29
Tx date 2018-11-06 		$CMTA
Clementia Pharmaceuticals Inc. 		Nader, Francois
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+11,990 vol
Filed 2018-11-29
Tx date 2018-11-06 		$CMTA
Clementia Pharmaceuticals Inc. 		Legault, Pierre
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+11,990 vol 		35,970
Filed 2018-11-29
Tx date 2018-11-06 		$CMTA
Clementia Pharmaceuticals Inc. 		Tomasello, Shawn Cline
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+11,990 vol 		35,970
Filed 2018-11-29
Tx date 2018-11-06 		$CMTA
Clementia Pharmaceuticals Inc. 		Heft, Robert
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+11,990 vol 		102,683
Filed 2018-11-29
Tx date 2018-11-06 		$CMTA
Clementia Pharmaceuticals Inc. 		Nader, Francois
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+11,990 vol 		102,683
Filed 2018-10-04
Tx date 2018-09-30 		$CMTA
Clementia Pharmaceuticals Inc. 		Bonita, David P.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
56 - Grant of rights
+1,597 vol 		4,303
Filed 2018-10-04
Tx date 2018-09-30 		$CMTA
Clementia Pharmaceuticals Inc. 		Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
56 - Grant of rights
+1,121 vol 		3,028
Filed 2018-10-04
Tx date 2018-09-30 		$CMTA
Clementia Pharmaceuticals Inc. 		Legault, Pierre
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
56 - Grant of rights
+1,205 vol 		2,245
Filed 2018-10-04
Tx date 2018-09-30 		$CMTA
Clementia Pharmaceuticals Inc. 		Tomasello, Shawn Cline
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
56 - Grant of rights
+896 vol 		896
Filed 2018-10-04
Tx date 2018-09-30 		$CMTA
Clementia Pharmaceuticals Inc. 		Heft, Robert
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
56 - Grant of rights
+896 vol 		2,315
Filed 2018-10-04
Tx date 2018-09-30 		$CMTA
Clementia Pharmaceuticals Inc. 		Nader, Francois
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
56 - Grant of rights
+952 vol 		2,460
Filed 2018-10-04
Tx date 2018-07-05 		$CMTA
Clementia Pharmaceuticals Inc. 		Tomasello, Shawn Cline
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
Filed 2018-07-16
Tx date 2018-07-12 		$CMTA
Clementia Pharmaceuticals Inc. 		Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+225,000 vol 		225,000
Filed 2018-07-16
Tx date 2018-07-12 		$CMTA
Clementia Pharmaceuticals Inc. 		Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2018-07-05
Tx date 2018-07-05 		$CMTA
Clementia Pharmaceuticals Inc. 		Tomasello, Shawn Cline
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$294,474
+23,980 vol
$12.28 each 		23,980
Filed 2018-07-05
Tx date 2018-07-05 		$CMTA
Clementia Pharmaceuticals Inc. 		Tomasello, Shawn Cline
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2018-07-04
Tx date 2018-06-30 		$CMTA
Clementia Pharmaceuticals Inc. 		Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
56 - Grant of rights
+1,021 vol 		1,907
Filed 2018-07-04
Tx date 2018-06-30 		$CMTA
Clementia Pharmaceuticals Inc. 		Bonita, David P.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
56 - Grant of rights
+1,448 vol 		2,706
Filed 2018-07-04
Tx date 2018-06-30 		$CMTA
Clementia Pharmaceuticals Inc. 		Heft, Robert
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
56 - Grant of rights
+759 vol 		1,419
Filed 2018-07-04
Tx date 2018-06-30 		$CMTA
Clementia Pharmaceuticals Inc. 		Legault, Pierre
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
56 - Grant of rights
+807 vol 		1,040
Filed 2018-07-04
Tx date 2018-06-30 		$CMTA
Clementia Pharmaceuticals Inc. 		Nader, Francois
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
56 - Grant of rights
+807 vol 		1,508
Filed 2018-04-20
Tx date 2018-04-17 		$CMTA
Clementia Pharmaceuticals Inc. 		Packman, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+40,000 vol 		248,879
Filed 2018-04-20
Tx date 2018-04-17 		$CMTA
Clementia Pharmaceuticals Inc. 		Grinstead, Eric
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+10,000 vol 		434,760
Filed 2018-04-20
Tx date 2018-04-17 		$CMTA
Clementia Pharmaceuticals Inc. 		Walewicz, Joseph Andrew
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+10,000 vol 		163,920
Filed 2018-04-20
Tx date 2018-04-17 		$CMTA
Clementia Pharmaceuticals Inc. 		Singer, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+20,000 vol 		362,390
Filed 2018-04-20
Tx date 2018-04-17 		$CMTA
Clementia Pharmaceuticals Inc. 		Shih, Fei
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+5,000 vol 		84,950
Filed 2018-04-20
Tx date 2018-04-17 		$CMTA
Clementia Pharmaceuticals Inc. 		Roy Grogan, Donna
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+40,000 vol 		394,894
Filed 2018-04-20
Tx date 2018-04-17 		$CMTA
Clementia Pharmaceuticals Inc. 		Desjardins, Clarissa
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+100,000 vol 		1,194,457
Filed 2018-04-17
Tx date 2017-08-14 		$CMTA
Clementia Pharmaceuticals Inc. 		Nader, Francois
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
Filed 2018-04-17
Tx date 2017-08-14 		$CMTA
Clementia Pharmaceuticals Inc. 		Nader, Francois
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
Filed 2018-04-17
Tx date 2018-03-31 		$CMTA
Clementia Pharmaceuticals Inc. 		Nader, Francois
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
56 - Grant of rights
+701 vol
Filed 2018-04-17
Tx date 2018-03-31 		$CMTA
Clementia Pharmaceuticals Inc. 		Nader, Francois
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
56 - Grant of rights
+701 vol
Filed 2018-04-17
Tx date 2018-03-31 		$CMTA
Clementia Pharmaceuticals Inc. 		Nader, Francois
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
56 - Grant of rights
+701 vol 		701
Filed 2018-04-17
Tx date 2017-08-14 		$CMTA
Clementia Pharmaceuticals Inc. 		Nader, Francois
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
Filed 2018-04-17
Tx date 2017-08-14 		$CMTA
Clementia Pharmaceuticals Inc. 		Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
Filed 2018-04-17
Tx date 2017-08-14 		$CMTA
Clementia Pharmaceuticals Inc. 		Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
Filed 2018-04-17
Tx date 2018-03-31 		$CMTA
Clementia Pharmaceuticals Inc. 		Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
56 - Grant of rights
+886 vol
Filed 2018-04-17
Tx date 2018-03-31 		$CMTA
Clementia Pharmaceuticals Inc. 		Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
56 - Grant of rights
+886 vol
Filed 2018-04-17
Tx date 2018-03-31 		$CMTA
Clementia Pharmaceuticals Inc. 		Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
56 - Grant of rights
+886 vol 		886
Filed 2018-04-17
Tx date 2017-08-14 		$CMTA
Clementia Pharmaceuticals Inc. 		Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
Filed 2018-04-17
Tx date 2018-03-31 		$CMTA
Clementia Pharmaceuticals Inc. 		Bonita, David P.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
56 - Grant of rights
+1,258 vol
Filed 2018-04-17
Tx date 2018-03-31 		$CMTA
Clementia Pharmaceuticals Inc. 		Bonita, David P.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
56 - Grant of rights
+1,258 vol 		1,258
Filed 2018-04-17
Tx date 2017-08-14 		$CMTA
Clementia Pharmaceuticals Inc. 		Heft, Robert
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
Filed 2018-04-17
Tx date 2017-08-14 		$CMTA
Clementia Pharmaceuticals Inc. 		Heft, Robert
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
Filed 2018-04-17
Tx date 2017-08-14 		$CMTA
Clementia Pharmaceuticals Inc. 		Heft, Robert
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
Filed 2018-04-17
Tx date 2018-03-31 		$CMTA
Clementia Pharmaceuticals Inc. 		Heft, Robert
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
56 - Grant of rights
+660 vol
Filed 2018-04-17
Tx date 2018-03-31 		$CMTA
Clementia Pharmaceuticals Inc. 		Heft, Robert
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
56 - Grant of rights
+660 vol
Filed 2018-04-17
Tx date 2018-03-31 		$CMTA
Clementia Pharmaceuticals Inc. 		Heft, Robert
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
56 - Grant of rights
+660 vol 		660
Filed 2018-04-17
Tx date 2018-01-31 		$CMTA
Clementia Pharmaceuticals Inc. 		Legault, Pierre
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
Filed 2018-04-17
Tx date 2018-01-31 		$CMTA
Clementia Pharmaceuticals Inc. 		Legault, Pierre
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
Filed 2018-04-17
Tx date 2018-01-31 		$CMTA
Clementia Pharmaceuticals Inc. 		Legault, Pierre
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
Filed 2018-04-17
Tx date 2018-03-31 		$CMTA
Clementia Pharmaceuticals Inc. 		Legault, Pierre
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
56 - Grant of rights
+233 vol
Filed 2018-04-17
Tx date 2018-03-31 		$CMTA
Clementia Pharmaceuticals Inc. 		Legault, Pierre
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
56 - Grant of rights
+233 vol
Filed 2018-04-17
Tx date 2018-03-31 		$CMTA
Clementia Pharmaceuticals Inc. 		Legault, Pierre
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
56 - Grant of rights
+233 vol 		233
Filed 2018-04-17
Tx date 2017-08-14 		$CMTA
Clementia Pharmaceuticals Inc. 		Bonita, David P.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
Filed 2018-04-17
Tx date 2017-08-14 		$CMTA
Clementia Pharmaceuticals Inc. 		Bonita, David P.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
Filed 2018-04-17
Tx date 2017-08-14 		$CMTA
Clementia Pharmaceuticals Inc. 		Bonita, David P.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
Filed 2018-04-17
Tx date 2018-03-31 		$CMTA
Clementia Pharmaceuticals Inc. 		Bonita, David P.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
56 - Grant of rights
+1,258 vol
Filed 2018-04-16
Tx date 2018-03-31 		$CMTA
Clementia Pharmaceuticals Inc. 		Nader, Francois
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
56 - Grant of rights
+701 vol 		701
Filed 2018-04-16
Tx date 2018-03-31 		$CMTA
Clementia Pharmaceuticals Inc. 		Legault, Pierre
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
56 - Grant of rights
+233 vol 		233
Filed 2018-04-16
Tx date 2017-08-14 		$CMTA
Clementia Pharmaceuticals Inc. 		Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
Filed 2018-04-16
Tx date 2018-03-31 		$CMTA
Clementia Pharmaceuticals Inc. 		Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
56 - Grant of rights
+886 vol 		886
Filed 2018-04-16
Tx date 2017-08-14 		$CMTA
Clementia Pharmaceuticals Inc. 		Nader, Francois
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
Filed 2018-04-16
Tx date 2017-08-14 		$CMTA
Clementia Pharmaceuticals Inc. 		Bonita, David P.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
Filed 2018-04-16
Tx date 2018-03-31 		$CMTA
Clementia Pharmaceuticals Inc. 		Bonita, David P.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
56 - Grant of rights
+1,258 vol 		1,258
Filed 2018-04-16
Tx date 2017-08-14 		$CMTA
Clementia Pharmaceuticals Inc. 		Heft, Robert
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
Filed 2018-04-16
Tx date 2018-03-31 		$CMTA
Clementia Pharmaceuticals Inc. 		Heft, Robert
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
56 - Grant of rights
+660 vol 		660
Filed 2018-04-16
Tx date 2018-01-31 		$CMTA
Clementia Pharmaceuticals Inc. 		Legault, Pierre
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
Filed 2018-03-05
Tx date 2018-02-27 		$CMTA
Clementia Pharmaceuticals Inc. 		Legault, Pierre
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$330,924
+23,980 vol
$13.80 each 		23,980
Filed 2018-03-05
Tx date 2018-02-27 		$CMTA
Clementia Pharmaceuticals Inc. 		Walewicz, Joseph Andrew
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		95,920
Filed 2018-03-05
Tx date 2018-02-27 		$CMTA
Clementia Pharmaceuticals Inc. 		Walewicz, Joseph Andrew
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+58,000 vol 		153,920
Filed 2018-03-05
Tx date 2018-02-27 		$CMTA
Clementia Pharmaceuticals Inc. 		Legault, Pierre
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$330,924
+23,980 vol
$13.80 each
Filed 2018-03-02
Tx date 2018-02-27 		$CMTA
Clementia Pharmaceuticals Inc. 		Grinstead, Eric
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+60,000 vol 		424,760
Filed 2018-03-02
Tx date 2018-02-27 		$CMTA
Clementia Pharmaceuticals Inc. 		Desjardins, Clarissa
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+305,000 vol 		1,094,457
Filed 2018-03-02
Tx date 2017-08-14 		$CMTA
Clementia Pharmaceuticals Inc. 		Grinstead, Eric
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2018-03-02
Tx date 2017-08-14 		$CMTA
Clementia Pharmaceuticals Inc. 		Grinstead, Eric
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2018-03-02
Tx date 2017-08-14 		$CMTA
Clementia Pharmaceuticals Inc. 		Grinstead, Eric
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		364,760
Filed 2018-03-02
Tx date 2018-01-31 		$CMTA
Clementia Pharmaceuticals Inc. 		Legault, Pierre
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2018-03-02
Tx date 2018-02-27 		$CMTA
Clementia Pharmaceuticals Inc. 		Legault, Pierre
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$330,924
+23,980 vol
$13.80 each 		23,980
Filed 2018-03-02
Tx date 2018-02-27 		$CMTA
Clementia Pharmaceuticals Inc. 		Packman, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+40,000 vol 		208,879
Filed 2018-03-02
Tx date 2018-02-27 		$CMTA
Clementia Pharmaceuticals Inc. 		Roy Grogan, Donna
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+60,000 vol 		354,894
Filed 2018-03-02
Tx date 2018-02-27 		$CMTA
Clementia Pharmaceuticals Inc. 		Shih, Fei
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		59,950
Filed 2018-03-02
Tx date 2018-02-27 		$CMTA
Clementia Pharmaceuticals Inc. 		Shih, Fei
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+20,000 vol 		79,950
Filed 2018-03-02
Tx date 2018-02-27 		$CMTA
Clementia Pharmaceuticals Inc. 		Singer, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+90,000 vol 		342,390
Filed 2017-08-23
Tx date 2017-08-14 		$CMTA
Clementia Pharmaceuticals Inc. 		Nader, Francois
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-08-23
Tx date 2017-08-14 		$CMTA
Clementia Pharmaceuticals Inc. 		Roy Grogan, Donna
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		294,894
Filed 2017-08-23
Tx date 2017-08-14 		$CMTA
Clementia Pharmaceuticals Inc. 		Roy Grogan, Donna
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		69,866
Filed 2017-08-23
Tx date 2017-08-14 		$CMTA
Clementia Pharmaceuticals Inc. 		Packman, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		168,879
Filed 2017-08-23
Tx date 2017-08-14 		$CMTA
Clementia Pharmaceuticals Inc. 		Packman, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-08-23
Tx date 2017-08-14 		$CMTA
Clementia Pharmaceuticals Inc. 		Packman, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		104,685
Filed 2017-08-23
Tx date 2017-08-14 		$CMTA
Clementia Pharmaceuticals Inc. 		Packman, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-08-23
Tx date 2017-08-14 		$CMTA
Clementia Pharmaceuticals Inc. 		Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		130,691
Filed 2017-08-23
Tx date 2017-08-14 		$CMTA
Clementia Pharmaceuticals Inc. 		Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		58,751
Filed 2017-08-23
Tx date 2017-08-14 		$CMTA
Clementia Pharmaceuticals Inc. 		Heft, Robert
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		90,693
Filed 2017-08-23
Tx date 2017-08-14 		$CMTA
Clementia Pharmaceuticals Inc. 		Grinstead, Eric
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		366,211
Filed 2017-08-23
Tx date 2017-08-14 		$CMTA
Clementia Pharmaceuticals Inc. 		Grinstead, Eric
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-08-23
Tx date 2017-08-14 		$CMTA
Clementia Pharmaceuticals Inc. 		Bonita, David P.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		35,970
Filed 2017-08-23
Tx date 2017-08-14 		$CMTA
Clementia Pharmaceuticals Inc. 		Bonita, David P.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-08-23
Tx date 2017-08-14 		$CMTA
Clementia Pharmaceuticals Inc. 		Heft, Robert
4 - Director of Issuer
Holder: Gren Trust (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report 		63,895
Filed 2017-08-23
Tx date 2017-08-14 		$CMTA
Clementia Pharmaceuticals Inc. 		Morrell Mott, David
4 - Director of Issuer
Holder: New Enterprise Associates 15, L.P. (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report 		2,140,246
Filed 2017-08-23
Tx date 2017-08-14 		$CMTA
Clementia Pharmaceuticals Inc. 		Nader, Francois
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-08-23
Tx date 2017-08-14 		$CMTA
Clementia Pharmaceuticals Inc. 		Nader, Francois
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		103,329
Filed 2017-08-23
Tx date 2017-08-14 		$CMTA
Clementia Pharmaceuticals Inc. 		Nader, Francois
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		90,693
Filed 2017-08-23
Tx date 2017-08-14 		$CMTA
Clementia Pharmaceuticals Inc. 		Morrell Mott, David
4 - Director of Issuer
Holder: New Enterprise Associates 15, L.P. (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-08-22
Tx date 2017-08-14 		$CMTA
Clementia Pharmaceuticals Inc. 		Desjardins, Clarissa
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		789,457
Filed 2017-08-22
Tx date 2017-08-14 		$CMTA
Clementia Pharmaceuticals Inc. 		Desjardins, Clarissa
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		814,054
Filed 2017-08-22
Tx date 2017-08-14 		$CMTA
Clementia Pharmaceuticals Inc. 		Bonita, David P.
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		35,970
Filed 2017-08-22
Tx date 2017-08-14 		$CMTA
Clementia Pharmaceuticals Inc. 		Grinstead, Eric
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		366,211
Filed 2017-08-22
Tx date 2017-08-14 		$CMTA
Clementia Pharmaceuticals Inc. 		Nader, Francois
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		103,329
Filed 2017-08-22
Tx date 2017-08-14 		$CMTA
Clementia Pharmaceuticals Inc. 		Singer, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		252,390
Filed 2017-08-22
Tx date 2017-08-14 		$CMTA
Clementia Pharmaceuticals Inc. 		Singer, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		26,378
Filed 2017-08-22
Tx date 2017-08-14 		$CMTA
Clementia Pharmaceuticals Inc. 		Packman, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		168,879
Filed 2017-08-22
Tx date 2017-08-14 		$CMTA
Clementia Pharmaceuticals Inc. 		Packman, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		104,685
Filed 2017-08-22
Tx date 2017-08-14 		$CMTA
Clementia Pharmaceuticals Inc. 		Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Private Investments IV, LP (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report 		10,425,225
Filed 2017-08-22
Tx date 2017-08-14 		$CMTA
Clementia Pharmaceuticals Inc. 		Nader, Francois
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		90,693
Filed 2017-08-22
Tx date 2017-08-14 		$CMTA
Clementia Pharmaceuticals Inc. 		Morrell Mott, David
4 - Director of Issuer
Holder: New Enterprise Associates 15, L.P. (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report 		2,140,246